Table of Content

1. Introduction to Gulf Cooperation Council (GCC) Pharmaceutical Market

1.1 Overview
1.2 GCC Pharmaceutical Market Analysis


2. GCC Pharmaceutical Market by Indication - Prevalence & Statistics

2.1 Cancer
2.1.1 Overview
2.1.2 Prevalence by Cancer Type & Gender
2.1.3 Cancer Prevalence & Statistics by GCC Countries
2.2 Diabetes
2.3 HIV/AIDS
2.4 Cardiovascular Diseases
2.4.1 Coronary Heart Disease
2.4.2 Hypertension
2.4.3 Stroke
2.5 Obesity
2.6 Respiratory Disorders
2.6.1 Asthma
2.6.2 Tuberculosis
2.6.3 Influenza & Pneumonia
2.6.4 Other Respiratory Diseases - COPD & Cystic Fibrosis
2.7 Alzheimer’s Disease/Dementia


3. GCC - Regulatory Aspects of Pharmaceuticals

3.1 Gulf Central Committee for Drug Registrations (GCC-DR)
3.2 Regulatory Review Process
3.3 Centralized Registration
3.4 Decentralized Drug Registration Regulation
3.4.1 Saudi Arabia
3.4.2 Kuwait
3.4.3 UAE
3.4.4 Bahrain
3.4.5 Qatar
3.4.6 Oman
3.5 Gulf Joint Procurement Program


4. GCC - Pharmaceutical Pricing & Reimbursement Policies

4.1 Pricing Policies
4.1.1 In-Patent Pharmaceuticals
4.1.2 Off-Patent & Generic Pharmaceuticals
4.1.3 Locally & Multinational Manufactured Pharmaceuticals
4.2 Procurement & Reimbursement Policies
4.2.1 In-Patent Pharmaceuticals
4.2.2 Off-Patent, Generics & Biosimilars


5. GCC Pharmaceutical Market by Product

5.1Generics Pharmaceuticals
5.2 Patented & OTC Pharmaceuticals
5.3 Biosimilars


6. Saudi Arabia Pharmaceutical Market Analysis

6.1 Overview
6.2 Saudi Arabia Pharmaceutical Market by Products
6.3 Saudi Arabia Pharmaceutical Market by Companies
6.4 Saudi Arabia Pharmaceutical Market by Type



7. UAE Pharmaceutical Market Analysis

7.1 Overview
7.2 UAE Pharmaceuticals Market by Product
7.3 UAE Pharmaceutical Market by Companies
7.4 UAE Pharmaceutical Market by Type


8. Kuwait Pharmaceutical Market Analysis

8.1 Overview
8.2 Kuwait Pharmaceutical Market by Therapeutic Indication & Products
8.3 Kuwait Pharmaceutical Market by Companies
8.4 Kuwait Pharmaceutical Market by Type


9. Bahrain Pharmaceutical Market Analysis

9.1 Overview
9.2 Bahrain Pharmaceutical Market by Products
9.3 Bahrain Pharmaceutical market by Companies
9.4 Bahrain Pharmaceutical Market by Product Type


10. Qatar Pharmaceutical Market Analysis

10.1 Overview
10.2 Qatar Pharmaceutical Market by Type


11. Oman Pharmaceutical Market Analysis

11.1 Overview
11.2 Oman Pharmaceutical Market by Product Type



12. GCC Pharmaceutical Market - International Trade

12.1 Import Market
12.2 Pharmaceutical Export Market


13. GCC Pharmaceutical Market - Clinical Insight

13.1 Overview
13.2 Clinical Trials by Indication
13.2.1 Cancer
13.2.2 Diabetes
13.2.3 CVS Disorders
13.2.4 Respiratory Disorders
13.3 Clinical Insight by GCC Countries
13.3.1 Saudi Arabia
13.3.2 United Arab Emirates
13.3.3 Kuwait
13.3.4 Bahrain
13.3.5 Qatar
13.3.6 Oman


14. GCC Pharmaceutical Market Drivers


15. Challenges for GCC Pharmaceutical Market


16. GCC Pharmaceutical Market Future Outlook - Trends & Opportunities


17. Competitive Landscape

17.1 Local Pharmaceutical Companies
17.1.1 Julphur Pharmaceuticals
17.1.2 SPIMACO Addwaeih
17.1.3 Qatar Life Pharma
17.1.4 Al Mojil Drug Company
17.1.5 Kuwait Saudi Pharmaceutical Company
17.1.6 YIACO Medical Company
17.1.7 Qatar Pharma
17.1.8 Saja Pharmaceuticals
17.1.9 Oman Pharmaceuticals
17.1.10 Taiba Pharmaceuticals
17.1.11 Gulf Biotech
17.1.12 Bahrain Pharma
17.1.13 Neopharma
17.1.14 Planet Pharmacies
17.1.15 Aljazeera Pharmaceutical Industries
17.1.16 Dallah Pharma
17.1.17 Tabuk Pharmaceuticals
17.1.18 CAD Middle-East Pharmaceutical Company
17.1.19 ACDIMA
17.1.20 AL-Mufid Pharmaceuticals

17.2 Multinational Companies
17.2.1 Novartis
17.2.2 Amgen
17.2.3 Eli - Lilly
17.2.4 Merck
17.2.5 Pfizer
17.2.6 GlaxoSmithKline plc
17.2.7 Roche
17.2.8 Takeda Pharmaceuticals
17.2.9 Teva Pharmaceuticals
17.2.10 AstraZeneca plc
17.2.11 Genentech
17.2.12 Sanofi



List of Figures


Figure 1-1: Pharmaceutical Market Size - Global vs. GCC (US$ Billion), 2018
Figure 1-2: GCC vs. Rest of World - Pharmaceutical Market Size (%), 2018
Figure 1-3: GCC - Population Statistics (Million), 2019
Figure 1-4: GCC - Population by Countries (%), 2019
Figure 1-5: GCC - Healthcare Expenditure by Countries (US$ Billion), 2018
Figure 1-6: GCC - Healthcare Expenditure by Countries (%), 2018
Figure 1-7: GCC - Pharmaceutical Market Size (US$ Billion), 2016 & 2018
Figure 1-8: GCC Pharmaceutical Market Size (US$ Billion), 2018 - 2025
Figure 1-9: MEA vs. GCC - Pharmaceutical Market Size (US$ Billion), 2018
Figure 1-10: GCC vs. Rest of MEA - Pharmaceutical Market Size (%), 2018
Figure 1-11: GCC - Pharmaceutical Market Size by Countries (US$ Billion), 2018
Figure 1-12: Pharmaceutical Market Size of Various GCC Countries (%), 2018

Figure 2-1: GCC - Number of Newly Diagnosed Cancer Cases & Deaths, 2018
Figure 2-2: GCC - Number of New Cancer Cases by Countries, 2018
Figure 2-3: GCC - New Cancer Cases by Countries (%), 2018
Figure 2-4: GCC - Number of Cancer Related Deaths by Countries, 2018
Figure 2-5: GCC - New Cancer Cases by Countries (%), 2018
Figure 2-6: GCC - Number of Newly Diagnosed Cancer Cases, 2018 & 2030
Figure 2-7: GCC - Age Standardized Cancer Incidence Rate by Countries (per 100,000 People), 2018
Figure 2-8: GCC - Age Standardized Cancer Mortality Rate by Countries (per 100,000 People), 2018
Figure 2-9: GCC Pharmaceutical Market Size - Total vs. Cancer Drugs (US$ Billion), 2018
Figure 2-10: GCC - Cancer Drug Market Size by Countries (%), 2018
Figure 2-11: GCC - Number of New Diagnosed Cases by Cancer Type, 2018
Figure 2-12: GCC - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-13: GCC - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-14: GCC - Cancer Cases by Gender (%), 2018
Figure 2-15: GCC - Cancer Deaths by Gender (%), 2018
Figure 2-16: GCC - Age Standardized Cancer Incidence & Mortality Rate (per 100,000 People), 2018
Figure 2-17: Saudi Arabia - Number of Cancer Cases & Deaths, 2018
Figure 2-18: Saudi Arabia - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-19: Saudi Arabia - New Diagnosed Cancer Cases by Gender (%), 2018
Figure 2-20: Saudi Arabia - Cancer Related Deaths by Gender (%), 2018
Figure 2-21: Saudi Arabia - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-22: UAE - Number of Cancer Cases & Deaths, 2018
Figure 2-23: UAE - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-24: UAE - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-25: UAE - Number of New Diagnosed Cases by Cancer Type, 2018
Figure 2-26: Kuwait - Number of Cancer Cases & Deaths, 2018
Figure 2-27: Kuwait - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-28: Kuwait - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-29: Kuwait - Number of New Diagnosed Cases by Cancer Type, 2018
Figure 2-30: Bahrain - Number of Cancer Cases & Deaths, 2018
Figure 2-31: Bahrain - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-32: Bahrain - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-33: Bahrain - Number of New Diagnosed Cases by Cancer Type, 2018
Figure 2-34: Qatar - Number of Cancer Cases & Deaths, 2018
Figure 2-35: Qatar - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-36: Qatar - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-37: Qatar - Number of New Diagnosed Cases by Cancer Type, 2018
Figure 2-38: Oman - Number of Cancer Cases & Deaths, 2018
Figure 2-39: Oman - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-40: Oman - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-41: Oman - Number of New Diagnosed Cases by Cancer Type, 2018
Figure 2-42: GCC - Total Adult Population & Diabetic Population (Million), 2017
Figure 2-43: GCC - Total Adult Population & Diabetic Population (%), 2017
Figure 2-44: GCC - Diabetic Population by Countries (Million), 2017
Figure 2-45: GCC - Diabetic Population by Countries (%), 2017
Figure 2-46: GCC - Diabetes Related Deaths by Countries, 2017
Figure 2-47: GCC - Diabetes Related Deaths by Countries (%), 2017
Figure 2-48: GCC - Diabetes Prevalence Rate by Countries (%), 2017
Figure 2-49: GCC - Age Standardized Diabetes Death Rate by Countries (Per 100,000 People), 2017
Figure 2-50: GCC - Diabetic Population (Billion), 2017, 2018 & 2045
Figure 2-51: Saudi Arabia - Total HIV Cases & Newly Diagnosed HIV Cases, 2017
Figure 2-52: Saudi Arabia - New Diagnosed HIV Cases, 2013 - 2017
Figure 2-53: Saudi Arabia - New Diagnosed HIV Cases by Gender, 2017
Figure 2-54: Saudi Arabia - New Diagnosed HIV Cases by Gender (%), 2017
Figure 2-55: Saudi Arabia - Total HIV Cases by Gender, 2017
Figure 2-56: Saudi Arabia - Total HIV Cases by Gender, 2017
Figure 2-57: Saudi Arabia - Cumulative HIV Related Deaths by Gender, 2017
Figure 2-58: Saudi Arabia - Cumulative Number of HIV Patients on Anti-retroviral Therapy, 2017
Figure 2-59: UAE - Cumulative Number of HIV Patients, 2012, 2014 & 2016
Figure 2-60: UAE - Number of New HIV Cases & Deaths, 2016
Figure 2-61: UAE - Cumulative Number of HIV Patients on Anti-retroviral Therapy, 2012, 2014 & 2018
Figure 2-62: UAE - Cumulative Number of HIV Patients, 2014 - 2018
Figure 2-63: Bahrain - HIV Associated New Cases & Deaths, 2016
Figure 2-64: Bahrain - Patients Receiving Antiretroviral Therapy (%), 2012, 2014 & 2016
Figure 2-65: Qatar - Cumulative Number of HIV Cases & Patients on Antiretroviral Therapy, 1984 - 2014
Figure 2-66: Qatar - HIV Patients on Anti-Retroviral Therapy, 1984 - 2014
Figure 2-67: Oman - Cumulative HIV Cases, 2014, 2016 & 2018
Figure 2-68: Oman - Cumulative HIV Cases by Gender, 2018
Figure 2-69: Oman - Cumulative HIV Cases by Gender (%), 2018
Figure 2-70: Oman - Cumulative HIV Cases by Age, 2018
Figure 2-71: GCC - Age Standardized Coronary Heart Disease Death Rate by Countries, 2017
Figure 2-72: GCC - CHD Related Deaths by Countries, 2017
Figure 2-73: GCC - CHD Related Deaths by Countries (%), 2017
Figure 2-74: GCC - Age Standardized Hypertension Death Rate by Countries, 2017
Figure 2-75: GCC - Hypertension Related Deaths by Countries, 2017
Figure 2-76: GCC - Hypertension Related Deaths by Countries (%), 2017
Figure 2-77: GCC - Age Standardized Stroke Death Rate by Countries, 2017
Figure 2-78: GCC - Stroke Related Deaths by Countries, 2017
Figure 2-79: GCC - Stroke Related Deaths by Countries (%), 2017
Figure 2-80: GCC - Obese Population by Countries (%), 2019
Figure 2-81: GCC - Body Mass Index by Countries, 2019
Figure 2-82: Saudi Arabia - Obesity Prevalence Rate (%), 2017 & 2022
Figure 2-83: Saudi Arabia - Obesity Prevalence Rate by Gender (%), 2017 & 2022
Figure 2-84: UAE - Prevalence Rate of Obesity & Overweight by Gender (%), 2016
Figure 2-85: UAE - Obese Adult Population (%), 2019
Figure 2-86: Kuwait - Prevalence Rate of Obesity & Overweight (%), 2016
Figure 2-87: Kuwait - Prevalence Rate of Obesity & Overweight by Gender (%), 2016
Figure 2-88: Bahrain - Prevalence Rate of Obesity & Overweight (%), 2016
Figure 2-89: Bahrain - Prevalence Rate of Obesity & Overweight by Gender (%), 2016
Figure 2-90: Qatar - Prevalence Rate of Obesity & Overweight (%), 2016
Figure 2-91: Qatar - Prevalence Rate of Obesity & Overweight by Gender (%), 2016
Figure 2-92: Oman - Obesity Prevalence Rate by Gender (%), 2016
Figure 2-93: GCC - Asthma Related Deaths by Countries, 2017
Figure 2-94: GCC - Asthma Related Deaths by Countries (%), 2017
Figure 2-95: GCC - Age Standardized Asthma Death Rate by Countries (per 100,000 People), 2017
Figure 2-96: GCC - Tuberculosis Related Deaths by Countries, 2017
Figure 2-97: GCC - Age Standardized Incidence Rate of Tuberculosis by Countries (Per 100,000 People), 2017
Figure 2-98: GCC - Asthma Related Deaths by Countries (%), 2017
Figure 2-99: GCC - Age Standardized Tuberculosis Death Rate by Countries (per 100,000 People), 2017
Figure 2-100: GCC - Influenza & Pneumonia Related Deaths by Countries, 2017
Figure 2-101: GCC - Influenza & Pneumonia Related Deaths by Countries (%), 2017
Figure 2-102: GCC - Age Standardized Influenza & Pneumonia Death Rate by Countries (per 100,000 People), 2017
Figure 2-103: GCC - COPD Prevalence Rate by Countries (%), 2018
Figure 2-104: GCC - COPD & Cystic Fibrosis Related Deaths by Countries, 2017
Figure 2-105: GCC - COPD & Cystic Fibrosis Related Deaths by Countries (%), 2017
Figure 2-106: GCC - Age Standardized COPD & Cystic Fibrosis Death Rate by Countries (per 100,000 People), 2017
Figure 2-107: GCC - Alzheimer/Dementia Related Deaths by Countries, 2017
Figure 2-108: GCC - Alzheimer/Dementia Related Deaths by Countries (%), 2017
Figure 2-109: GCC - Age Standardized Alzheimer/Dementia Death Rate by Countries (per 100,000 People), 2017

Figure 3-1: GCC - Types of Drug Registration Process
Figure 3-2: Process Map for GCC Centralized Registration
Figure 3-3: GCC - Innovative/Biological and Generic Drug Registration Fees for Evaluation Procedures (SAR/US$), 2019
Figure 3-4: GCC - Innovative/Biological and Generic Drug Registration Renewal Fees (SAR/US$), 2019
Figure 3-5: GCC - Registration Fees for Addition of New Pharmaceutical Form, New Strength & New Pack Size for Innovative/Biological Products (SAR/US$), 2019
Figure 3-6: GCC - Registration Fees for Addition of New Pharmaceutical Form, New Strength & New Pack Size for Generic Products (SAR/US$), 2019
Figure 3-7: GCC - Registration Fees for Addition of New Pharmaceutical Form, New Strength & New Pack Size for Intravenous Generic Products (SAR/US$), 2019
Figure 3-8: Saudi Arabia - Regulatory Process for Pharmaceuticals
Figure 3-9: Kuwait - Regulatory Process for Pharmaceuticals
Figure 3-10: UAE - Regulatory Process for Pharmaceuticals
Figure 3-11: Bahrain - Regulatory Process for Pharmaceuticals
Figure 3-12: Qatar - Regulatory Process for Pharmaceuticals
Figure 3-13: Oman - Regulatory Process for Pharmaceuticals

Figure 5-1: GCC - Pharmaceutical Market Size - Generic vs. Others (US$ Billion), 2018
Figure 5-2: GCC - Pharmaceutical Market Size - Generic vs. Others (%), 2018
Figure 5-3: GCC - Generic Drug Market Size (US$ Billion), 2018 - 2025
Figure 5-4: GCC - Patented & OTC Pharmaceutical Market Size (US$ Billion), 2018
Figure 5-5: GCC - Share of Patented Products in Pharmaceutical Market by Countries (%), 2016
Figure 5-6: GCC - Share of OTC Products in Pharmaceutical Market by Countries (%), 2016
Figure 5-7: GCC - Biosimilars Market Size (US$ Million), 2019 & 2025
Figure 5-8: GCC - Strategies Considered by New Biosimilars Manufacturers
Figure 5-9: Key Stakeholders for Launch of Biosimilars

Figure 6-1: Pharmaceutical Market Size - Saudi Arabia vs. Rest of GCC (%), 2018
Figure 6-2: Pharmaceutical Market Size - Saudi Arabia vs. Rest of MEA (%), 2018
Figure 6-3: Saudi Arabia - Pharmaceutical Market Size (US$ Billion), 2018 - 2025
Figure 6-4: Saudi Arabia - Pharmaceutical Market Share by Channel of Distribution (%), 2018
Figure 6-5: Saudi Arabia - Pharmaceutical Market Size by indication (%), 2018
Figure 6-6: Saudi Arabia - Number of New Product Launched by Indication, 2018
Figure 6-7: Saudi Arabia - Sales Data of Leading Pharmaceutical Products (US$ Million), 2018
Figure 6-8: Saudi Arabia - Revenue of Leading Pharmaceutical Companies (US$ Million), 2018
Figure 6-9: Saudi Arabia - Generic & Branded Pharmaceutical Market Size (%), 2018
Figure 6-10: Saudi Arabia - OTC & Prescribed Pharmaceuticals Market Size (US$ Billion), 2018
Figure 6-11: Saudi Arabia - OTC & Prescribed Pharmaceutical Market Size (%), 2018

Figure 7-1: Pharmaceutical Market Size - UAE vs. Rest of GCC (%), 2018
Figure 7-2: Pharmaceutical Market Size - UAE vs. Rest of MEA (%), 2018
Figure 7-3: UAE - Pharmaceutical Market Size by Channel of Distribution (%), 2018
Figure 7-4: UAE - Pharmaceutical Market Size (US$ Billion), 2018 - 2025
Figure 7-5: UAE - Pharmaceutical Export Market by Region (%), 2017
Figure 7-6: UAE - Pharmaceutical Export Market by Countries (%), 2017
Figure 7-7: UAE - Pharmaceutical Export Market by Products (%), 2018
Figure 7-8: UAE - Pharmaceutical Market Size by Therapeutic Indication (US$ Million), 2018
Figure 7-9: UAE - Number of New Launched Pharmaceutical Product by Indication, 2018
Figure 7-10: UAE - Growth Rate of Leading Pharmaceutical Companies (%), 2018
Figure 7-11: UAE - Pharmaceutical Market Share by Type of Products (%), 2017
Figure 7-12: UAE - Pharmaceutical Market Share by Type of Products (%), 2018
Figure 7-13: UAE - Generic Drug Market Size (US$ Million), 2017 - 2025

Figure 8-1: Pharmaceutical Market Size - Kuwait vs. Rest of GCC (%), 2018
Figure 8-2: Pharmaceutical Market Size - Kuwait vs. Rest of MEA (%), 2018
Figure 8-3: Kuwait - Pharmaceutical Market Size (US$ Billion), 2018-2025
Figure 8-4: Kuwait - Pharmaceutical Market Size by Therapeutic Indication (%), 2018
Figure 8-5: Kuwait - Sales Data of Leading Pharmaceutical Products (US$ Million), 2018
Figure 8-6: Kuwait - Pharmaceutical Market Size - MNC vs. Regional Companies (%), 2016
Figure 8-7: Kuwait - Julphar Pharmaceutical Share in Regional Pharmaceutical sales (%), 2016
Figure 8-8: Kuwait - Pharmaceutical Market Size by Leading Companies (US$ Million), 2018
Figure 8-9: Kuwait - Generic Pharmaceutical Market Share (%), 2018 & 2025
Figure 8-10: Kuwait - Pharmaceutical Market by Type of Product (%), 2018
Figure 8-11: Kuwait - Generic Drug Market Share in Total market Size (%), 2018
Figure 8-12: Kuwait - OTC Pharmaceutical Market Share (%), 2018 & 2025

Figure 9-1: Bahrain - Pharmaceutical Market Size - Bahrain vs. Rest of GCC (%), 2018
Figure 9-2: Bahrain - Pharmaceutical Market Size (US$ Million), 2018 - 2025
Figure 9-3: Bahrain - Pharmaceutical Market Size - Import vs. Total Market (US$ Million), 2018
Figure 9-4: Bahrain - Pharmaceutical market Share - Import vs. Other Market (%), 2018
Figure 9-5: Bahrain - Pharmaceutical market Share by Therapeutic Agents (%), 2018
Figure 9-6: Bahrain - Market Size by Leading Pharmaceutical Companies (US$ Million), 2018
Figure 9-7: Bahrain - Share of Generics in Total Pharmaceutical Market (%) 2018 & 2025
Figure 9-8: Bahrain - Share of OTC in Total Pharmaceutical Market (%) 2018 & 2025
Figure 9-9: Bahrain - Patented, Generics & OTC Pharmaceuticals Market Share (%), 2018
Figure 9-10: Bahrain - Patented, Generics & OTC Pharmaceuticals Market Share (%), 2025
Figure 9-11: Bahrain - Generic Pharmaceutical Market Size (US$ Million), 2018 & 2025
Figure 9-12: Bahrain - OTC Pharmaceutical Market Size (US$ Million), 2018 & 2025

Figure 10-1: Qatar - Pharmaceutical Market Size (US$ Million), 2015 - 2018
Figure 10-2: Qatar - Pharmaceutical Market Size - Qatar vs. Rest of GCC (%), 2018
Figure 10-3: Qatar - Pharmaceutical Market Size - Qatar vs. Rest of MEA (%), 2018
Figure 10-4: Qatar - Pharmaceutical Market Size (US$ Million), 2018 - 2025
Figure 10-5: Qatar - Pharmaceutical Market Size by Product Type (US$ Million), 2018
Figure 10-6: Qatar - Pharmaceutical Market Size by Product Type (%), 2018
Figure 10-7: Qatar - Pharmaceutical Market Size by Type of Product (US$ Million), 2025

Figure 11-1: Oman - Pharmaceutical Market Size (US$ Million), 2012, 2016 & 2018
Figure 11-2: Pharmaceutical Market Size - Oman vs. Rest of GCC (%), 2018
Figure 11-3: Pharmaceutical Market Size - Oman vs. Rest of MEA (%), 2018
Figure 11-4: Oman - Pharmaceutical Market Size (US$ million), 2019 - 2025
Figure 11-5: Oman - Import, Export & Other Pharmaceutical Market Size (US$ Million), 2018
Figure 11-6: Oman - Import, Export & Other Pharmaceutical Market Size (%), 2018
Figure 11-7: Oman - Share of Generics in Total Pharmaceutical Market (%) 2016, 2018 & 2025
Figure 11-8: Oman - Share of OTC in Total Pharmaceutical Market (%) 2016, 2018 & 2025
Figure 11-9: Oman - Patented, Generics & OTC Pharmaceuticals Market Share (%), 2018
Figure 11-10: Oman - Patented, Generics & OTC Pharmaceuticals Market Share (%), 2025
Figure 11-11: Oman - Generic Pharmaceutical Market Size (US$ Million), 2018 & 2025
Figure 11-12: Oman - OTC Pharmaceutical Market Size (US$ Million), 2018 & 2025
Figure 12-1: GCC - Pharmaceutical Import Market Size by Countries (US$ Billion), 2018
Figure 12-2: GCC - Pharmaceutical Import Market Size by Countries (%), 2018
Figure 12-3: GCC - Import Pharmaceutical Market Size (US$ Billion), 2016, 2017 & 2018
Figure 12-4: Saudi Arabia - Pharmaceutical Import Size (US$ Billion), 2016 - 2018
Figure 12-5: UAE - Pharmaceutical Import Size (US$ Billion), 2016 - 2018
Figure 12-6: Kuwait - Pharmaceutical Import Size (US$ Billion), 2016 - 2018
Figure 12-7: Bahrain - Pharmaceutical Import Size (US$ Million), 2016 - 2018
Figure 12-8: Qatar - Pharmaceutical Import Size (US$ Million), 2016 - 2018
Figure 12-9: Oman - Pharmaceutical Import Size (US$ Million), 2016 - 2018
Figure 12-10: GCC - Pharmaceutical Export Market Size by Countries (US$ Million), 2018
Figure 12-11: GCC - Pharmaceutical Export Market Size by Countries (%), 2018
Figure 12-12: GCC - Export Pharmaceutical Market Size (US$ Billion), 2016, 2017 & 2018
Figure 12-13: Saudi Arabia - Pharmaceutical Export Size (US$ Million), 2016 - 2018
Figure 12-14: UAE - Pharmaceutical Export Size (US$ Million), 2016 - 2018
Figure 12-15: Kuwait - Pharmaceutical Export Size (US$ Million), 2016 - 2018
Figure 12-16: Bahrain - Pharmaceutical Export Size (US$ Million), 2016 - 2018
Figure 12-17: Qatar - Pharmaceutical Export Size (US$ Million), 2016 - 2018
Figure 12-18: Oman - Pharmaceutical Export Size (US$ Million), 2016 - 2018

Figure 13-1: GCC - Number of Clinical Trials by Countries, 2019
Figure 13-2: GCC - Clinical Trials by Countries (%), 2019
Figure 13-3: GCC - Number of Clinical Trials by Status, 2019
Figure 13-4: GCC - Clinical Trials by Status (%), 2019
Figure 13-5: GCC - Number of Clinical Trial by Phase, 2019
Figure 13-6: GCC - Number of Clinical Trial by Phase (%), 2019
Figure 13-7: GCC - Numbers of Clinical Trials by Indications, 2019
Figure 13-8: GCC - Clinical Trials by Indications (%), 2019
Figure 13-9: GCC - Number of Cancer Related Clinical Trials by Countries, 2019
Figure 13-10: GCC - Cancer Related Clinical Trials by Countries (%), 2019
Figure 13-11: GCC - Number of Cancer Related Clinical Trials by Phase of Development, 2019
Figure 13-12: GCC - Number of Diabetes Related Clinical Trials by Countries, 2019
Figure 13-13: GCC - Diabetes Related Clinical Trials by Countries (%), 2019
Figure 13-14: GCC - Number of Diabetes Related Clinical Trials by Development Phase, 2019
Figure 13-15: GCC - Number of CVS Disorder Related Clinical Trials by Countries, 2019
Figure 13-16: GCC - CVS Disorder Related Clinical Trials by Countries (%), 2019
Figure 13-17: GCC - Number of CVS Disorders Related Clinical Trials by Development Phase, 2019
Figure 13-18: GCC - Number of Respiratory Disorder (Except Lung Cancer) Related Clinical trials by Countries, 2019
Figure 13-19: GCC - Respiratory Disorder (Except Lung Cancer) Related Clinical Trials by Countries (%), 2019
Figure 13-20: GCC - Number of Respiratory Disorders Related Clinical Trials by Development Phase, 2019
Figure 13-21: Saudi Arabia - Number of Clinical Trials by Development Phase, 2019
Figure 13-22: Saudi Arabia - Number of Clinical Trials by Status, 2019
Figure 13-23: Saudi Arabia - Numbers of Clinical Trials by Indications, 2019
Figure 13-24: Saudi Arabia - Clinical Trials by Indications (%), 2019
Figure 13-25: UAE - Clinical Trials in States of UAE (%), 2019
Figure 13-26: UAE - Number of Clinical Trials by Development Phase, 2019
Figure 13-27: UAE - Number of Clinical Trials by Status, 2019
Figure 13-28: UAE - Numbers of Clinical Trials by Indications, 2019
Figure 13-29: UAE - Clinical Trials by Indications (%), 2019
Figure 13-30: Kuwait - Number of Clinical Trials by Development Phase, 2019
Figure 13-31: Kuwait - Number of Clinical Trials by Status, 2019
Figure 13-32: Kuwait - Numbers of Clinical Trials by Indications, 2019
Figure 13-33: Kuwait - Clinical Trials by Indications (%), 2019
Figure 13-34: Bahrain - Number of Clinical Trials by Development Phase, 2019
Figure 13-35: Bahrain - Number of Clinical Trials by Status, 2019
Figure 13-36: Qatar - Number of Clinical Trials by Development Phase, 2019
Figure 13-37: Qatar - Number of Clinical Trials by Status, 2019
Figure 13-38: Qatar - Numbers of Clinical Trials by Indications, 2019
Figure 13-39: Kuwait - Clinical Trials by Indications (%), 2019
Figure 13-40: Oman - Number of Clinical Trials by Development Phase, 2019
Figure 13-41: Oman - Number of Clinical Trials by Status, 2019

Figure 14 1: Driving Factors for GCC Pharmaceutical Market

Figure 15-1: Challenges for GCC Pharmaceutical Market

Figure 16-1: GCC - Population Forecast by Countries (Million), 2025
Figure 16-2: GCC - Pharmaceutical Market Forecast by Countries (US$ Billion), 2025
Figure 16-3: GCC - Pharmaceutical Market Share Forecast by Countries (%), 2025
Figure 16-4: GCC - Cancer Drug Market Forecast (US$ Billion), 2018 & 2025
Figure 16-5: GCC - Generic Pharmaceutical Market Forecast (%), 2025